RALEIGH, N.C. (AP) - Salix Pharmaceuticals Ltd. said Wednesday that the Food and Drug Administration approved its drug Fulyzaq, which is designed to treat diarrhea in patients taking HIV and AIDS drugs. Its shares rose more than 5 percent in midday trading.
Salix said it plans to start marketing the drug in early 2013. The company said Fulyzaq could have up to five years of marketing exclusivity, meaning similar products won't be approved in that time.
The drug is designed to treat diarrhea in patients with HIV or AIDS who are on anti-retroviral therapy. Salix says many patients who are taking anti-retroviral drugs experience episodic or chronic diarrhea, which can lead to weight loss and affect compliance with the treatment.
Salix said Fulyzaq, or crofelemer, is the first FDA-approved botanical drug that is intended to be taken orally. The active ingredient in the drug is derived from the sap of a tree called Croton lechleri, and is commonly known as "dragon's blood" because of the red color of the sap. The ingredient is isolated and purified after the sap is extracted.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Cold and breezy with snow increasing in coverage into the overnight hours.
News 4 was contacted by a concerned parent who believes the Ken-Ton Board of Education is trying to censor parents at PTA meetings.
A Salamanca man has been charged with DWI after a traffic accident in the Town of Little Valley Saturday.
JOHANNESBURG (AP) — U.S. President Barack Obama implored thousands gathered in a cold, rainy stadium and millions watching around the world on Tuesday to carry forward Nelson Mandela's mission of erasing injustice and inequality.
America's oldest state park is in the midst of a major makeover and officials are giving a clearer picture of what's next for Niagara Falls.
A second arrest has now been made in connection to a suspected meth lab on Saunders Settlement Road in Cambria.